From: Customized yeast cell factories for biopharmaceuticals: from cell engineering to process scale up
Host | Therapeutic protein | Yield | Reference |
---|---|---|---|
P. pastoris | Insulin | 3Â g/L Insulin precursor | [122] |
S. cerevisiae | IFNα2b | 15 mg/L | [142] |
Y. lipolytica | IFNα2b | 425 mg/L | [143] |
P. pastoris | Hepatitis B antigen | 7Â g/L | [144] |
S. cerevisiae | Glucagon like peptide 2 | – | [145] |
K. lactis | Human interferon β | – | [40] |
P. pastoris | Human granulocyte–macrophage colony-stimulating factor | 285 mg/L | [146] |
P. pastoris | Human serum albumin | 92.29Â mg/L | [147] |
H. polymorpha | HBV surface antigen | 250Â mg/L | [148] |
H. polymorpha | Granulocyte colony stimulating factor (GCSF) | – | [26] |
H. polymorpha | Rotavirus VP6 protein (RV VP6) | 3350.71Â mg/L | [149] |
H. polymorpha | HPV type 16 L1-L2 chimeric protein (SAF) | 132.10Â mg/L | [25] |